fig2

From: Systemic delivery of large-scale manufactured Wharton's Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction

Systemic delivery of large-scale manufactured Wharton's Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction

Figure 2. Flow cytometry analysis of the EV products. (A) Representative scatter plots showing the analyzed EV population. (B) Positive expression of FITC+/CD63+ EVs (dark gray) compared to isotype control (light gray). (C) Positive expression of APC+/CD81+ EVs (black) compared to isotype control (light gray). (D) The calculated CD63 and CD81 positive expression of the EV products collected at the 48 and 120 h collection time points. EVs: Extracellular vesicles; PLT: human platelet lysate; FBS: fetal bovine serum.

fig2

Committee on Publication Ethics

Portico

Committee on Publication Ethics

Portico